Downregulation of EZH2 inhibits epithelial-mesenchymal transition in enzalutamide-resistant prostate cancer. Zhang Z, Wang X, Kim M, He D, et al. Prostate 2023 Jul 20. doi: 10.1002/pros.24602.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang Z, Wang X, Kim M, He D, et al. Downregulation of EZH2 inhibits epithelial-mesenchymal transition in enzalutamide-resistant prostate cancer. Prostate 2023 Jul 20. doi: 10.1002/pros.24602.
PMID: 37475584